Inspire Medical Systems, Inc. (INSP): who owns it and who trades it
As of Nov 16, 2026, INSP insiders reported 7 open-market sales worth $666K and no purchases in the last 12 months, with 70% of the sale value made under pre-set 10b5-1 plans. The largest seller was Shawn mcCormick (Director), with $453K. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Inspire Medical Systems
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns INSP
276 funds and institutions reported INSP shares worth $1.7B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 16.4%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 4.74M | 16.44% | $211M | +33% |
| Wellington Management Group LLP | 2.38M | 8.27% | $106M | -6% |
| Vanguard Portfolio Management LLC | 2.09M | 7.25% | $93.2M | +28% |
| Soleus Capital Management, L.P. | 1.93M | 6.70% | $86.2M | +235% |
| AQR Capital Management LLC | 1.86M | 6.44% | $80.9M | +502% |
| Assenagon Asset Management S.A. | 1.73M | 6.00% | $77.1M | +232% |
| UBS Group AG | 1.65M | 5.71% | $73.4M | +158% |
| D. E. Shaw & Co., Inc. | 1.47M | 5.10% | $65.6M | +24% |
| Nomura Holdings Inc | 1.37M | 4.75% | $61.1M | – |
| California State Teachers Retirement System | 1.32M | 4.57% | $29.5M | +3721% |
| Deerfield Management Company, L.P. | 1.30M | 4.50% | $57.9M | -52% |
| Vanguard Capital Management LLC | 1.27M | 4.41% | $56.7M | +0% |
| State Street Corp | 1.21M | 4.19% | $53.8M | +26% |
| Morgan Stanley | 791,222 | 2.75% | $35.3M | -45% |
| Artisan Partners Limited Partnership | 732,323 | 2.54% | $32.7M | -6% |
| Geode Capital Management, LLC | 700,836 | 2.43% | $31.3M | +37% |
| Braidwell LP | 677,570 | 2.35% | $30.2M | No change |
| Goldman Sachs Group Inc | 645,858 | 2.24% | $28.8M | -3% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 546,020 | 1.90% | $24.4M | +22% |
| Nantahala Capital Management, LLC | 538,948 | 1.87% | $24M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, INSP insiders reported $0 of open-market purchases and $666K of sales. 70% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Jason P Kelly | See Remarks | Sale | 963 | $59.55 | $57.3K | Form 4 |
| May 15, 2026 | John Rondoni | See Remarks | Sale | 2,641 | $43.28 | $114K | Form 4 |
| May 14, 2026 | John Rondoni | See Remarks | Sale | 700 | $43.01 | $30.1K | Form 4 |
| May 8, 2026 | Shawn mcCormick | Director | Sale plan | 696 | $45.31 | $31.5K | Form 4 |
| Jan 9, 2026 | John Rondoni | See Remarks | Sale plan | 109 | $100.00 | $10.9K | Form 4 |
| Dec 2, 2025 | Shawn mcCormick | Director | Sale plan | 1,200 | $139.00 | $167K | Form 4 |
| Nov 28, 2025 | Shawn mcCormick | Director | Sale plan | 2,000 | $127.48 | $255K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Shawn mcCormick | Director | – | $453K | May 8, 2026 |
| John Rondoni | See Remarks | – | $155K | May 15, 2026 |
| Jason P Kelly | See Remarks | – | $57.3K | Aug 7, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
INSP short interest
High short interest. 14.3% of INSP shares are sold short: about 1 share in 7. Over the last 12 reports the number of shares short went up 13%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.14M INSP shares were sold short, 14.3% of the shares outstanding, down 7.7% from the report before. At the average daily volume of 625,586 shares, buying them all back would take about 6.6 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.14M | 14.31% | -8% | 625,586 | 6.6 |
| Oct 15, 2026 | 4.49M | 15.54% | +7% | 1.00M | 4.5 |
| Sep 30, 2026 | 4.20M | 14.51% | +7% | 906,711 | 4.6 |
| Sep 15, 2026 | 3.93M | 13.59% | +7% | 795,398 | 4.9 |
| Aug 31, 2026 | 3.66M | 12.65% | -16% | 488,000 | 7.5 |
| Aug 14, 2026 | 4.37M | 15.13% | +12% | 841,529 | 5.2 |
| Jul 31, 2026 | 3.92M | 13.56% | -10% | 781,458 | 5.0 |
| Jul 15, 2026 | 4.34M | 15.08% | -7% | 1.04M | 4.2 |
| Jun 30, 2026 | 4.69M | 16.29% | +31% | 1.23M | 3.8 |
| Jun 15, 2026 | 3.59M | 12.46% | -3% | 951,982 | 3.8 |
| May 29, 2026 | 3.70M | 12.83% | +0% | 1.19M | 3.1 |
| May 15, 2026 | 3.68M | 12.78% | +15% | 1.75M | 2.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Inspire Medical Systems company events
Inspire Medical Systems filed 10 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 2, 2026.
- Nov 2, 2026ResultsReleased financial results. Filing
- Aug 3, 2026ResultsReleased financial results. Filing
- Jul 24, 2026LeadershipThe Board of Directors of Inspire Medical Systems, Inc., upon the recommendation of its Nominating and Corporate Governance Committee, appointed Michael H. Carrel to the Board, effective immediately. Filing
- Jul 22, 2026LeadershipCasey Tansey, a member of the Board of Directors of Inspire Medical Systems, Inc., notified the Company of his decision to retire from the Board (and the committees on which he serves) and not stand for re-election at the Company’s 2027 Annual Meeting of Stockholders. Filing
- Jun 26, 2026AnnouncementShared information with investors. Filing
- May 5, 2026LeadershipAs reported below under Item 5.07 of this Current Report on Form 8-K (this “Current Report”), on April 30, 2026, Inspire Medical Systems, Inc. held its 2026 Annual Meeting of Stockholders, at which the Company’s stockholders approved an amendment and restatement of the Inspire Medical Systems, Inc.… Filing
- May 4, 2026ResultsReleased financial results. Filing
- Feb 11, 2026ResultsReleased financial results. Filing
- Jan 12, 2026LeadershipThe Board of Directors of the Company approved the appointment of Matthew J. Osberg as Chief Financial Officer, effective as of the day after the Company files its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Filing
- Nov 17, 2025AnnouncementInspire Medical Systems, Inc. disclosed its expectation to release a significant portion of the valuation allowance on its U.S. deferred tax assets during the fourth quarter of fiscal 2025. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Inspire Medical Systems financials
Famous investors that hold INSP
5 of the 50 well-known investors we track reported holding INSP in their latest 13F filing. The largest position is Ken Griffin's, worth $57.4M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 828,088 | $57.4M | 0.0% | +64% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 499,400 | $34.6M | 0.0% | +17% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 394,612 | $27.4M | 0.0% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 104,499 | $7.2M | 0.0% | -38% |
| Israel Englander · Millennium Management | Q3 2026 | 2,926 | $203K | 0.0% | -97% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 8 filings named INSP in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | D. E. Shaw & Co., L.P. | 13G/A | 4.2% |
| Nov 16, 2026 | D. E. Shaw & Co., L.P. | 13G/A | 4.2% |
| Nov 12, 2026 | AQR Capital Management, LLC | 13G/A | 2.9% |
| Nov 12, 2026 | AQR Capital Management, LLC | 13G/A | 2.9% |
| Nov 9, 2026 | Soleus Capital Master Fund, L.P. | 13G/A | 4.2% |
| Nov 9, 2026 | Soleus Capital Master Fund, L.P. | 13G/A | 4.2% |
| Oct 30, 2026 | Vanguard Portfolio Management | 13G/A | 6.0% |
| Oct 30, 2026 | Vanguard Portfolio Management | 13G/A | 6.0% |
Questions about Inspire Medical Systems, Inc. (INSP) stock
Who owns the most INSP stock?
The largest reported owner of Inspire Medical Systems, Inc. (INSP) is BlackRock, Inc., with 16.4% of the company. In total, 276 funds and institutions reported holding INSP at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are INSP insiders buying or selling?
In the last 12 months, INSP insiders reported no open-market purchases and 7 sales worth $666K. The latest trade was on Aug 7, 2026. See every trade.
What is the short interest in INSP?
As of Oct 30, 2026, 4.14M INSP shares were sold short, 14.3% of the shares outstanding, down 7.7% from the report before. At the average daily volume of 625,586 shares, buying them all back would take about 6.6 trading days (days to cover). See the history.
Which famous investors hold INSP?
5 of the 50 well-known investors we track reported INSP in their latest 13F filing, including Ken Griffin, Jim Simons, Steve Cohen. The largest position is worth $57.4M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.